716. A randomised-controlled feasibility study of ketamine for the treatment of depression with anorexia nervosa
The International Journal of Neuropsychopharmacology September 9, 2026 Johanna Keeler, Hubertus Himmerich, Janet Treasure et al.
Abstract Background Approximately a third of people with anorexia nervosa (AN) develop a severe and enduring form of the illness, which is often accompanied by depression. This can be a key barrier to recovery. Anti-depressant medications are less effective in treating depression in patients with acute AN, thus new pharmacological treatment options are needed. Ketamine is currently used for...